To mitigate supply chain risks in Asian medical device procurement, establish strong relationships with reputable suppliers, diversify your sourcing, conduct thorough supplier audits, and implement robust quality control measures. Additionally, develop contingency plans for potential disruptions and monitor regional geopolitical, economic, and... Read More
The key quality assurance factors to consider when sourcing in Asia include selecting reliable suppliers with good manufacturing practices (GMP), conducting thorough inspections and audits, monitoring the production process, and ensuring compliance with relevant regulations and standards. Effective communication and strong relationships... Read More
The top countries for medical device sourcing in Asia are China, Malaysia, India, and Taiwan. These countries have well-established medical device industries, advanced manufacturing capabilities, and a wide range of suppliers that can offer competitive pricing and quality products to global customers. Read More
To obtain a Unique Device Identification (UDI) for a medical device in China, manufacturers must apply to the Center for Medical Device Evaluation (CMDE) of the National Medical Products Administration (NMPA) and provide detailed information about the device. The CMDE will review... Read More
The key steps in the NMPA registration process for medical devices in China include determining the device classification, preparing the application and documents, submitting the application to the NMPA, and undergoing the review and evaluation process. Once approved, the device will receive... Read More
The review process for a Drug Master File (DMF) in China involves submitting the DMF to the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). The CDE will review the DMF for completeness and compliance with regulations, and... Read More
A China DMF (Drug Master File) should include information about the quality, safety, and efficacy of the API/excipient/packaging material, as well as information about the manufacturing, processing, packaging, and labeling of the drug component. Other information, such as analytical methods, stability data,... Read More
To submit a DMF (Drug Master File) to the Chinese regulatory authorities, a manufacturer of an API/excipient/packaging material needs to prepare the DMF documentation and file it with the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). The... Read More
Yes, an approved China DMF (Drug Master File) can be amended or updated. Changes to the DMF must be submitted to the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) for review and approval. The updated DMF will... Read More
Several factors can influence the cost of sourcing medical devices from Asia, including the complexity of the device, the quantity ordered, the location of the manufacturer, and the shipping and handling costs. Other factors such as taxes, import fees, and regulatory compliance... Read More